Articles by Amanda Shipman - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Amanda Shipman

Cell-Culture–Based Manufacturing: Meeting the Challenge of 21st Century Influenza

Influenza vaccines traditionally required yearly redevelopment to address changes in flu strains. With breakthrough technologies, however, the variables of yearly redevelopment can be reduced—accelerating time to market while reducing costs.
Aug 2, 2007

Vaccines against strains originating from avian flu may achieve poor yields in egg-based systems. Consequently, both public and private interest in alternative systems is high.

ADVERTISEMENT

ADVERTISEMENT

Click here